Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3853324

O=C(Nc1cccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)c1)c1ccc(F)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.48
GRK2 P25098 2/20 0.48
MTOR P42345 1/20 0.43
BLK P51451 1/20 0.43
BMX P51813 1/20 0.43
JAK3 P52333 1/20 0.43
BTK Q06187 1/20 0.43
SLC2A1 P11166 2/20 0.42
KIT P10721 5/20 0.42
LDLR P01130 1/20 0.42
PCSK9 Q8NBP7 1/20 0.42
PDGFRB P09619 1/20 0.42
ROCK2 O75116 1/20 0.40
CLK4 Q9HAZ1 4/20 0.40
CYP3A4 P08684 3/20 0.40
LMNA P02545 3/20 0.40
HIF1A Q16665 2/20 0.40
CYP1A2 P05177 2/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3852001 0.95 AKT1 (0.50) AKT1GRK2MTORBLKBMX
Trifluoroacetic Acid SCHEMBL3846056 0.93 GRK2 (0.47) AKT1GRK2MTORBLKBMX
Trifluoroacetic Acid SCHEMBL3846582 0.90 NTRK1 (0.48) AKT1GRK2MTORBLKBMX
Trifluoroacetic Acid SCHEMBL3847414 0.89 AKT1 (0.46) AKT1GRK2MTORBLKBMX
Trifluoroacetic Acid SCHEMBL3845037 0.88 AKT1 (0.53) AKT1MTORBLKBMXJAK3
Trifluoroacetic Acid SCHEMBL3846430 0.87 AKT1 (0.48) AKT1MTORBLKBMXJAK3
Trifluoroacetic Acid SCHEMBL3847006 0.85 AKT1 (0.50) AKT1GRK2MTORBLKBMX
Trifluoroacetic Acid SCHEMBL3855041 0.85 CYP1A2 (0.58) AKT1MTORBLKBMXJAK3
Trifluoroacetic Acid SCHEMBL3845990 0.84 AKT1 (0.53) AKT1SLC2A1KITROCK2CLK4
Trifluoroacetic Acid SCHEMBL3849091 0.84 CYP3A4 (0.47) AKT1MTORBLKBMXJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed